Biotia

We’re thrilled to share that Woman’s World has featured Biotia in their latest article! Our groundbreaking work in the field of urinary infectious diseases, especially UTIs, is gaining well-deserved attention. We’ve just received approval for the BIOTIA-ID Urine NGS Assay as a Laboratory Developed Test — making it the first genomics-based urine assay to tackle UTIs and other urinary infections at a molecular level. This is a huge step forward in the fight against UTIs, offering faster, more accurate diagnoses and paving the way for better patient outcomes. #Biotia #InnovationInHealthcare #UTI #Genomics #Biotechnology #HealthcareInnovation #WomensHealth

Earlier this week, we were proud to announce that the New York State Department of Health has approved Biotia’s AI- and sequencing-based Urinary Tract Infection Test. This approval marks a significant step forward in transforming how UTIs are diagnosed—making the process faster, more precise, and more accessible. Catch the full coverage of this exciting news from GenomeWeb, who broke the story earlier this week. We’re excited about what this means for the future of healthcare and the impact it will have on patient outcomes. #Biotia #UTI #AI #Genomics #HealthTech #Diagnostics #Innovation #Healthcare

Biotia Gets First-Ever NY State Regulatory Approval for a Urine Infectious Disease Test Powered by Genomics and AI We are thrilled to share big news at Biotia! After years of development and regulatory review, our BIOTIA-ID Urine NGS Assay has received New York State Department of Health regulatory approval! This is a major milestone for Biotia, as well as clinicians and patients seeking cutting-edge UTI tests which are more informative and accurate. This is especially important for patients suffering from recurrent or complicated UTIs. More about the test: - Unmatched Accuracy: 97% sensitivity and 99% specificity, far surpassing traditional methods. - AI-Powered: Our advanced machine learning algorithms deliver rapid and precise results. - Comprehensive: Identifies a broader range of pathogens, including those often missed by culture. Learn more about BIOTIA-ID and its potential to transform UTI diagnostics: https://lnkd.in/emQGZy6w #UTI #diagnostics #womenshealth #precisionmedicine #AI #innovation #healthcare

We're #hiring a new NYS Clinical Lab Supervising Technologist in New York, New York. Apply today or share this post with your network.

Join Mara Couto-Rodriguez, MS, Director of R&D, and Dr. Dorottya Nagy-Szakal MD PhD, Chief Medical Officer, as they present groundbreaking research at ID Week in Los Angeles! When: Saturday, October 19, 2024 Time: 12:15 PM – 1:30 PM Session: Diagnostics: Typing/Sequencing Presentations: P-2159: Potential Application of a Clinical-Grade Next Generation Sequencing Assay for Detection of Bacterial Vaginosis Associated Organisms in Urine P-2165: Comprehensive Next-Generation Sequencing-Based Assay for Antimicrobial Resistance Gene Marker Identification in Urine Stay tuned for insights and updates from the conference! #IDWeek2024 #InfectiousDiseases #Biotia

This year has brought a surge in dengue across the world associated with higher temperatures. Another reminder it is essential to track these threats across nations and model drivers of infections.

🔬Happy Global City Sampling Day! 🌎 Today, hundreds of scientists, researchers, and citizen volunteers are collecting samples from public spaces – subways, buses, airports, and more – across the globe. This data will create a genetic and epigenetic map of the diverse microbiomes in our cities. Want to see the magic happen in real time? Check out the interactive map on GeoSeeq. Follow the sampling efforts as they unfold, revealing where samples are being collected and stay tuned to see the results of how humans interact with the microbial world within cities. #GlobalCitySamplingDay #MetaSUB #GeoSeeq https://lnkd.in/e-wD_Hwy

Excited to share that our CMO, Dr. Dorottya Nagy-Szakal MD PhD and Director of R&D, Mara Couto-Rodriguez, are representing Biotia at American Society for Microbiology 2024 in NYC this week! If you're attending #ASMMicrobeNYC, be sure to stop by our booth to say hello and learn more about how Biotia is advancing the field of clinical microbiology and molecular diagnostics of infectious diseases. #ASMMicrobe #Microbiology #Biotia #Metagenomics

We are excited to share that our CEO and cofounder, Dr. Niamh B. O'Hara, will be speaking at Cornell Tech's HealthNext Summit. Join her at 1:50 PM ET on March 4th to hear about Biotia's work. #HealthNext2024 https://lnkd.in/eQRu9fja

Our CEO and cofounder, Dr. Niamh B. O'Hara, will be participating in the HealthNext Summit 2024 at Cornell Tech's Roosevelt Island campus in New York. This fantastic event brings together researchers, industry professionals, and stakeholders with a focus on exploring AI applications in healthcare. If you're attending, don't miss her lightning talk at 1:50 PM ET on March 4th.